Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
133,993,715
-
Share change
-
+1,037,838
-
Total reported value
-
$4,226,184,097
-
Put/Call ratio
-
76%
-
Price per share
-
$31.54
-
Number of holders
-
124
-
Value change
-
+$34,062,034
-
Number of buys
-
80
-
Number of sells
-
39
Institutional Holders of CEREVEL THERAPEUTICS HLDNG I - COM (CERE) as of Q4 2022
As of 31 Dec 2022,
CEREVEL THERAPEUTICS HLDNG I - COM (CERE) was held by
124 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
133,993,715 shares.
The largest 10 holders included
Bain Capital Investors LLC, FMR LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., STATE STREET CORP, FEDERATED HERMES, INC., Rock Springs Capital Management LP, and T. Rowe Price Investment Management, Inc..
This page lists
124
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.